Literature DB >> 25966129

Therapeutic influence of intraperitoneal injection of Wharton's jelly-derived mesenchymal stem cells on oviduct function and fertility in rats with acute and chronic salpingitis.

H J Luo1, X M Xiao2, J Zhou1, W Wei3.   

Abstract

To study the effect of Wharton's jelly-derived mesenchymal stem cells (WJMSCs) on the rat salpingitis model, 50 female Wistar rats were randomly divided into one control and five model groups. Mixed bacteria were injected into the oviducts of model groups. The treated acute and chronic groups received intraperitoneal injections of WJMSCs (1 x 10(6)) once a week for three weeks. Serum inflammation factor, collagen fiber content and oviduct-specific glycoprotein (OVGP) levels were detected in control, chronic, ex-treatment acute and chronic, and treated acute and chronic groups (N = 5 for each group). Pregnancy rate and litter size of control, chronic, treated acute and treated chronic groups were compared. Serum TNF-α and INF-γ levels increased in ex-treatment acute and chronic groups, and restored to normal in the acute treated group but not in the treated chronic group. Oviduct collagen fibers did not increase significantly before or after treatment in the acute group, but it increased in the ex-treatment chronic group and did not improve after treatment. After treatment, OVGP levels restored to normal in the acute group but reduced in the ex-treatment and treated chronic groups and chronic group. The pregnancy rate and litter size of the treated acute group recovered to normal, but in the treated chronic group and chronic model group, they decreased significantly. Thus, intraperitoneal injection of WJMSCs could recover the function of the oviduct in acute salpingitis rats, but its effect on chronic salpingitis was poor. Timely treatment of salpingitis is crucial to preserve reproductive function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25966129     DOI: 10.4238/2015.April.17.10

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

1.  Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease.

Authors:  Argyro Kagia; Maria Tzetis; Emmanuel Kanavakis; Despina Perrea; Irene Sfougataki; Anny Mertzanian; Ioanna Varela; Aikaterini Dimopoulou; Angeliki Karagiannidou; Evgenios Goussetis
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

Review 2.  Mesenchymal Stem Cells in Preclinical Infertility Cytotherapy: A Retrospective Review.

Authors:  Zhuo Chang; Hui Zhu; Xueming Zhou; Yang Zhang; Bei Jiang; Shuoxi Li; Lu Chen; Xue Pan; Xiao-Ling Feng
Journal:  Stem Cells Int       Date:  2021-05-17       Impact factor: 5.443

3.  Treatment evaluation of Wharton's jelly-derived mesenchymal stem cells using a chronic salpingitis model: an animal experiment.

Authors:  Zhe Li; Zhao Zhang; Xin Chen; Juan Zhou; Xiao-Min Xiao
Journal:  Stem Cell Res Ther       Date:  2017-10-17       Impact factor: 6.832

4.  Dental pulp stem cells-based therapy for the oviduct injury via immunomodulation and angiogenesis in vivo.

Authors:  Lihua Luo; Zhenjie Xing; Xiangyan Liao; Yejian Li; Yu Luo; Yilong Ai; Yan He; Qingsong Ye
Journal:  Cell Prolif       Date:  2022-07-12       Impact factor: 8.755

5.  Tracing GFP-labeled WJMSCs in vivo using a chronic salpingitis model: an animal experiment.

Authors:  Zhe Li; Zhao Zhang; Wai-Kit Ming; Xin Chen; Xiao-Min Xiao
Journal:  Stem Cell Res Ther       Date:  2017-12-01       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.